Cargando…
Validation of a Fully Automated HER2 Staining Kit in Breast Cancer
Background: Testing for HER2 amplification and/or overexpression is currently routine practice to guide Herceptin therapy in invasive breast cancer. At present, HER2 status is most commonly assessed by immunohistochemistry (IHC). Standardization of HER2 IHC assays is of utmost clinical and economica...
Autores principales: | Moelans, Cathy B., Kibbelaar, Robby E., van den Heuvel, Marius C., Castigliego, Domenico, de Weger, Roel A., van Diest, Paul J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619247/ https://www.ncbi.nlm.nih.gov/pubmed/20203372 http://dx.doi.org/10.3233/CLO-2010-0514 |
Ejemplares similares
-
Fully Automated Fluorescent in situ Hybridization (FISH) Staining and Digital Analysis of HER2 in Breast Cancer: A Validation Study
por: van der Logt, Elise M. J., et al.
Publicado: (2015) -
HER-2/neu Amplification Testing in Breast Cancer by Multiplex Ligation-Dependent Probe Amplification in Comparison with Immunohistochemistry and In Situ Hybridization
por: Moelans, Cathy B., et al.
Publicado: (2009) -
Multiplex Ligation-Dependent Probe Amplification to Detect HER2 Amplification in Breast Cancer: New Insights in Optimal Cut-Off Value
por: Moelans, Cathy B., et al.
Publicado: (2010) -
Molecular Differences between Ductal Carcinoma In Situ and Adjacent Invasive Breast Carcinoma: A Multiplex Ligation-Dependent Probe Amplification Study
por: Moelans, Cathy B., et al.
Publicado: (2010) -
HER-2/neu amplification testing in breast cancer by Multiplex Ligation-dependent Probe Amplification: influence of manual- and laser microdissection
por: Moelans, Cathy B, et al.
Publicado: (2009)